Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation

Recruiting now

Conditions studied: Sickle Cell Disease, Sickle Cell Anemia

In brief

The purpose of this research study is to document and understand the effects of hydroxyurea exposure for women with SCD and their babies, during both gestation and lactation.

Key facts

Study ID

NCT04093986

Run by

Children's Hospital Medical Center, Cincinnati

People needed

200

Starts

2019-12-22

Expected to finish

2030-12-31

Last updated by the study team

2026-06-18

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Medical records or data available from previous clinical care prior to June 20, 2019 of pregnant females with SCD, including women who miscarried, had a still birth, or completed labor at any gestational stage, with any hydroxyurea exposure during either pregnancy and/or while breastfeeding.
• Medical records or data available from previous clinical care prior to June 20, 2019 about pregnancy and breastfeeding outcomes, both for babies with hydroxyurea exposure and other babies by these same women.

You may not qualify if…

• Unavailable medical records or lack of information about hydroxyurea exposure.

Where it is running

• Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.